Advanced search
Publication Cover
The European Journal of Contraception & Reproductive Health Care Volume 8, 2003 - Issue 1
Submit an article Journal homepage
19
Views
3
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?

S. Özalp Department of Obstetrics and Gynecology, and *Department of Pathology, Osmangazi University School of Medicine, Eskisehir, Turkey
,
S. Kabukcuoglu Department of Obstetrics and Gynecology, and *Department of Pathology, Osmangazi University School of Medicine, Eskisehir, Turkey
&
H. M. Tanir Department of Obstetrics and Gynecology, and *Department of Pathology, Osmangazi University School of Medicine, Eskisehir, Turkey
Pages 17-20 | Published online: 06 Jul 2009

REFERENCES

  • World Health Organization. Mechanism of action, safety and efficacy of IUCDs. Technical Report Series. Geneva: WHO, 1987
  • Vessey MD. The Oxford Family Planning Association Contraceptive Study. Clin Obstet Gynecol 1983;90:201–9
  • Kulkarni S, Wynter HH, Desai P. Hysteroscopic assessment of abnormal uterine bleeding in users of the intrauterine contraceptive device. West Indian Med J 1993;42:124–5
  • Tadesse E, Wamsteker K. Evaluation of 24 patients with IUD-related problems: hysteroscopic findings. Eur J Obstet Gynecol Reprod Med 1985;19:37–41
  • Newton J. Contraception, sterilisation and abortion. In Shaw R, Soutter R, Stanton R, eds. Gynaecology. Edinburgh: Churchill Livingstone, 1992:291–324.
  • Eckert LO, Hawes SE, Wölner-Hanssen PK, et al. The clinical-pathologic syndrome. Am J Obstet Gynecol 2002;186:690–5
  • Kurman RJ, Kalminski PF, Norris HJ. The behaviour of endometrial hyperplasia: a long term study of under- treated hyperplasia in 170 patients. Cancer 1985;56:403–12
  • Verma V. Ultrastructural alterations in human endo- metrium caused by intrauterine contraceptive devices. Int J Gynaecol Obstet 1981;19:211–19
  • Shaw ST Jr, Macaulay LK, Sun NC, Tanaka MS Jr,Roche PC. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive device. Contraception 1983;27:131–40
  • Petrov IA, Kovaleva EA. Proliferative mucosal changes of the corpus and cervix uteri in women using intra- uterine contraceptives. Vopr Onkol 1986;32:49–52
  • Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002;57:120–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.